Related Experiment Video
Updated: Jun 5, 2026
06:07
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection
Ross B Mounsey1, Peter Teismann
1School of Medical Sciences, College of Life Sciences and Medicine, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK.
Parkinson'S Disease
|January 15, 2011
Summary
Mitochondrial dysfunction, particularly complex I impairment, is linked to Parkinson's disease (PD) pathogenesis. This review explores mitochondrial roles in idiopathic PD and assesses neuroprotective strategies targeting mitochondria.
Area of Science:
- Cell Biology
- Neuroscience
- Biochemistry
Background:
- Mitochondria are crucial for cellular energy production via oxidative phosphorylation.
- Mitochondrial dysfunction and oxidative stress are implicated in Parkinson's disease (PD) pathogenesis.
- Genetic factors in familial PD highlight the role of mitochondrial dysfunction.
Purpose of the Study:
- To review the role of mitochondria in idiopathic Parkinson's disease.
- To examine how genetic mutations affect mitochondrial activity in PD.
- To assess the progress of neuroprotective strategies targeting mitochondria.
Main Methods:
- Review of experimental models of Parkinson's disease.
- Analysis of genetic mutations influencing mitochondrial function.
- Assessment of recent neuroprotective interventions targeting mitochondria.
Main Results:
- Mitochondrial complex I impairment is a key factor in PD-related cell death.
- Genetic studies confirm the link between mitochondrial dysfunction and PD.
- Various experimental models support the role of mitochondria in PD.
Conclusions:
- Mitochondrial dysfunction is a significant contributor to idiopathic Parkinson's disease.
- Targeting mitochondria offers potential therapeutic strategies for PD.
- Further research into mitochondrial mechanisms is crucial for PD treatment.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:45Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...